Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
237.5 CHF | +0.04% | -2.22% | -9.03% |
Apr. 17 | Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial | MT |
Apr. 17 | Roche: positive phase III results in MS | CF |
Filters
- Stock Market
- Equities
- ROG Stock
- RO Stock
- News Roche Holding AG